| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |